MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients

Summary

This is a multi-centre, randomised, double-blind, placebo controlled, parallel group, Phase II study to evaluate efficacy and safety of 3 doses of MEDI7183, in Japanese subjects with moderate to severe UC

Timeline

Start

2013-11-21

Primary completion

2015-08-11

Completion

2018-04-10

Drugs

Indications